Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$ 2,055,068	$ 23,594,786
Adjustments to reconcile net income to net cash (used in) provided by operating activities:
Depreciation of property and equipment	4,697,717	2,592,244
Amortization of intangible assets	4,295,958	2,269,423
Amortization of finance lease right-of-use assets	2,822,982	2,391,989
Loss (gain) on disposal of assets	163,452	(42,667)
Deferred tax asset	1,049,236	0
Loss (gain) on equity method investments	301,362	(99,840)
Bad debt expense	(311,441)	2,702,979
Stock-based compensation	15,161,847	4,616,056
Gain on remeasurement of finance leases	(4,834)	(1,388,273)
Loss on liquidation of business	70,284	0
Gain on remeasurement of warrant liabilities	0	(1,137,070)
Change in fair value of contingent consideration	(159,974)	0
Changes in operating assets and liabilities:
Accounts receivable	(103,483,997)	2,894,650
Prepaid expenses and other current assets	(336,093)	(282,668)
Other assets	696,984	882,432
Accounts payable	(12,640,920)	(3,983,383)
Accrued liabilities	27,319,258	2,596,887
Net cash (used in) provided by operating activities	(58,303,111)	37,607,545
CASH FLOWS FROM INVESTING ACTIVITIES:
Acquisition of property and equipment	(4,360,807)	(1,994,161)
Acquisition of intangibles	(2,478,808)	(1,956,434)
Acquisition of businesses	(20,203,464)	(33,843,373)
Equity method investments	(150,510)	0
Proceeds from disposal of property and equipment	274,210	0
Net cash (used in) investing activities	(26,919,379)	(37,793,968)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from revolving credit line	0	1,000,000
Repayments of notes payable	(529,583)	(585,711)
Due to seller	(8,417,936)	(1,007,800)
Noncontrolling interest contributions	0	2,063,000
Proceeds from exercise of stock options	1,549,298	1,880,568
Payments for taxes related to shares withheld for employee taxes	(2,166,982)	0
Common stock repurchased	0	(497,759)
Equity costs	0	(19,570)
Payments on obligations under finance lease	(2,293,330)	(2,146,857)
Net cash (used in) provided by financing activities	(11,858,533)	685,871
Effect of exchange rate changes on cash and cash equivalents	227,887	(252,854)
Net (decrease) increase in cash and restricted cash	(96,853,136)	246,594
Cash and restricted cash at beginning of period	164,109,074	179,105,730
Cash and restricted cash at end of period	67,255,938	179,352,324
Supplemental disclosure of cash and non-cash transactions:
Cash paid for interest	179,430	102,203
Cash paid for interest on finance lease liabilities	394,443	434,580
Cash paid for income taxes	4,223,810	917,445
Right-of-use assets obtained in exchange for lease liabilities	2,407,938	4,094,731
Fixed assets acquired in exchange for notes payable	1,369,060	819,231
Receivable exchanged for trade credits	1,500,000	0
Reconciliation of cash and restricted cash
Cash	52,922,517	169,598,749
Restricted cash	14,333,421	9,753,575
Total cash and restricted cash shown in statement of cash flows	67,255,938	179,352,324
FMC NA
Supplemental disclosure of cash and non-cash transactions:
Acquisition of remaining FMC NA through due to seller and issuance of stock	7,000,000	0
CRMS
Supplemental disclosure of cash and non-cash transactions:
Acquisition of remaining FMC NA through due to seller and issuance of stock	$ 1,000,000	$ 0